LR1 on alternative treatment of the exposure measure - accounting balance sheet value
- Regulation
- Regulation (EU) No 575/2013 (CRR)
- Article
- 99
- Topic
- Supervisory reporting - Leverage ratio
- Submitted by
- Consultancy firm
- Submitted
- 2014-04-30
- Answered
- 2021-03-05
- Answer provided by
- ESAs (EBA, ESMA, EIOPA)
Question
Background
Answer
Original source: European Banking Authority, Q&A ID 2014_1131
This Q&A is published by European Banking Authority and is non-binding. It does not constitute legal advice. Updated weekly from official ESA sources.
Similar Q&As
Derivatives not shown in the Balance Sheet and Derivates shown as Liabilities
Answered 2017-04-07
CR IRB template – inclusion of haircut exposure value
Answered 2020-07-24
Scope of C40 LR1 Row 090
Answered 2019-10-04
Correct reporting in COREP Credit Risk Standardised Approach (CRSA) template of repo / SFT Positions with Cash Collateral CRM Substitution Effects
Answered 2017-04-07
Clarification of Value Adjustments according to Art. 111 of CRR2
Answered 2021-06-25
More Q&As on this topic
Reporting additional leverage ratio exposure amount in accordance with Article 3 CRR in C43.00
Answered 2026-07-03
Annex XI, INSTRUCTIONS FOR REPORTING ON LEVERAGE, Derivative cash collateral exposure reporting in C43 template
Answered 2025-08-29
Annex XI, INSTRUCTIONS FOR REPORTING ON LEVERAGE, C43 template {0040;0020} & {0050;0020}
Answered 2024-08-30
Calculation of “Total exposure” and other concepts in G 01.00 (G-SII indicators and EBU items)
Answered 2023-12-15
C43.00 (LR4) – Reporting of RWA for positions in CIUs
Answered 2023-09-22
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.